Precautions for osilodrostat

Osilodrostat is a drug used to treat Cushing's disease. Although it has significant efficacy, the following matters need to be paid attention to during use:

Osistrostat is mainly metabolized by the liver, so patients with hepatic insufficiency should use it with caution. Liver function should be checked regularly during treatment, especially the levels of liver enzymes (such as ALT, AST). If liver function abnormalities occur, dose adjustment or discontinuation may be required.

Oxidrostat may cause hypoglycemia, especially in patients with diabetes or those at risk for hypoglycemia. Symptoms of hypoglycemia include dizziness, sweating, palpitations, etc. Patients need to monitor blood sugar regularly and adjust hypoglycemic drug treatment in a timely manner.

Medications may cause edema or weight gain in the body. At the beginning of treatment, patients need to monitor weight changes and edema, especially patients with existing heart failure or renal insufficiency should use it with caution.

Although oxydrostat is primarily metabolized by the liver, it should be used with caution in patients with renal insufficiency. Patients with poor kidney function need to use it under the guidance of a doctor and have their kidney function evaluated regularly.

Osistrostat may interact with other drugs, especially withCYP3A4 inhibitors or inducers. When using other medications, your doctor should be informed and monitored for possible drug interactions.

The safety of oxidrostat in pregnant and lactating women is unknown and should be avoided in pregnant women. Consult your doctor if you plan to become pregnant or breast-feeding.

A small number of patients may experience mood swings or depressive symptoms, and patients with a history of mental illness need special attention.

Reference materials:https://isturisa.com/patient/